Director, Institute for Health Metrics and Evaluation, University of Washington, Seattle
Distinguished Lecture Series
The Global Burden of Disease Study is a collaboration of over 7,000 scientists who work together to produce annual assessments of disease incidence, prevalence, death and disability for 369 diseases or injuries for 204 countries and subnational units in 22 countries. The analysis also includes the burden of disease attributable to 87 risk factors. Each cycle of the GBD produces a comprehensive time series from 1990 to present. Over the thirty years of the GBD, a highly standardized statistical approach has been developed to deal with a range of common problems such as multiple case definitions, changes in measurement assays, missing data, conflicting data and the challenge of excluded groups in administrative data. The description of the data are available in the Global Health Data Exchange for the over 200,000 data sources used in the study. Key findings in the GBD 2019 highlight the range of major challenges facing the world. GBD 2020 will highlight a key methodological development and the impact of the COVID-19 pandemic. Associated with the GBD, IHME also generates forecasts of the entire GBD to 2050 using a set of validated statistical methods.
- Attendees will expand their knowledge with regard to the global burden of disease.
March 23, 2022
Not eligible for individual purchase must purchase as part of a meeting bundle.